A DOUBLE BLIND MULTICENTRIC RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF VRP 1620 IN INCREASING THE SENSITIVITY OF SCREEN FILM MAMMOGRAPHY AND LATERAL CHEST X RAY IN PATIENTS OF BREAST CANCER.

Trial Profile

A DOUBLE BLIND MULTICENTRIC RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF VRP 1620 IN INCREASING THE SENSITIVITY OF SCREEN FILM MAMMOGRAPHY AND LATERAL CHEST X RAY IN PATIENTS OF BREAST CANCER.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Sep 2016

At a glance

  • Drugs VRP 1620 (Primary)
  • Indications Breast cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Venus Remedies
  • Most Recent Events

    • 12 Sep 2016 Status changed from recruiting to completed.
    • 28 Apr 2014 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
    • 20 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top